Investing First patient dosed in Phase IIb imaging for Brain Mets by April 28, 2025 April 28, 2025 Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com previous post Binding Commitments Received for A$1.0 Million under Convertible Note Placement next post S&P 500 Rises from Bearish to Neutral, But Will It Last? You may also like NextSource Materials July 26, 2025 Teck Greenlights Highland Valley Expansion After Beating Q2... July 26, 2025 Editor’s Picks: Miners Rescued, US Mine Waste Strategy,... July 26, 2025 Pinnacle Increases Non-Brokered Private Placement July 26, 2025 Top 5 Canadian Mining Stocks This Week: St.... July 26, 2025 Biotech and Pharma Market Update: Q2 2025 in... July 25, 2025 Top 5 Canadian Biotech Stocks of 2025 July 25, 2025 Copper Price Update: Q2 2025 in Review July 25, 2025 Top 3 US Lithium Stocks of 2025 July 25, 2025 Blackstone Minerals July 25, 2025